Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R.
Int J Mol Sci. 2017 Mar 10;18(3):606. doi: 10.3390/ijms18030606.
Novel targets and therapies for keloid.
Naik PP.
Clin Exp Dermatol. 2022 Mar;47(3):507-515. doi: 10.1111/ced.14920. Epub 2021 Oct 10.
Pruritus in Keloid Scars: Mechanisms and Treatments.
Hawash AA, Ingrasci G, Nouri K, Yosipovitch G.
Acta Derm Venereol. 2021 Oct 28;101(10):adv00582. doi: 10.2340/00015555-3923.
Schwann cells contribute to keloid formation.
Direder M, Weiss T, Copic D, Vorstandlechner V, Laggner M, Pfisterer K, Mildner CS, Klas K, Bormann D, Haslik W, Radtke C, Farlik M, Shaw L, Golabi B, Tschachler E, Hoetzenecker K, Ankersmit HJ, Mildner M.
Matrix Biol. 2022 Apr;108:55-76. doi: 10.1016/j.matbio.2022.03.001. Epub 2022 Mar 10.
Histopathological differential diagnosis of keloid and hypertrophic scar.
Lee JY, Yang CC, Chao SC, Wong TW.
Am J Dermatopathol. 2004 Oct;26(5):379-84. doi: 10.1097/00000372-200410000-00006.
Keloid disease: Review with clinical atlas. Part I: Definitions, history, epidemiology, clinics and diagnosis.
Delaleu J, Charvet E, Petit A.
Ann Dermatol Venereol. 2023 Mar;150(1):3-15. doi: 10.1016/j.annder.2022.08.010. Epub 2022 Dec 7.
Keloids: a review of therapeutic management.
Ekstein SF, Wyles SP, Moran SL, Meves A.
Int J Dermatol. 2021 Jun;60(6):661-671. doi: 10.1111/ijd.15159. Epub 2020 Sep 9.
Keloid scarring or disease: Unresolved quasi-neoplastic tendencies in the human skin.
Ud-Din S, Bayat A.
Wound Repair Regen. 2020 May;28(3):422-426. doi: 10.1111/wrr.12793. Epub 2020 Feb 5.
Radiation therapy modalities for keloid management: A critical review.
Liu EK, Cohen RF, Chiu ES.
J Plast Reconstr Aesthet Surg. 2022 Aug;75(8):2455-2465. doi: 10.1016/j.bjps.2022.04.099. Epub 2022 May 6.
A keloid-like tumour.
Cataño JC, Londoño N.
Eur J Intern Med. 2024 Feb;120:116-117. doi: 10.1016/j.ejim.2023.12.004. Epub 2023 Dec 5.
